CD4 and tuberculosis: Santosuosso M. et al. [42] discovered that administering a recombinant adenovirus-based TB vaccine expressing Mtb Ag85A (AdAg85A) intranasally resulted in higher numbers of antigen-specific CD4+ and CD8+ T cells in the respiratory passage.